Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Dendreon patents

Patents where

Current Assignee

Name

Dendreon

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7279309 Process for manufacture of Nematode-extracted Anticoagulant Protein (NAP)	Patent 7279309 was granted and assigned to Dendreon on October, 2007 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7279309	October 9, 2007
‌ US Patent 7262211 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation	Patent 7262211 was granted and assigned to Dendreon on August, 2007 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7262211	August 28, 2007
‌ US Patent 7329640 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor	Patent 7329640 was granted and assigned to Dendreon on February, 2008 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7329640	February 12, 2008
‌ US Patent 7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof	Patent 7276364 was granted and assigned to Dendreon on October, 2007 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7276364	October 2, 2007
‌ US Patent 7597894 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease	Patent 7597894 was granted and assigned to Dendreon on October, 2009 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7597894	October 6, 2009
‌ US Patent 7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon	Patent 7700341 was granted and assigned to Dendreon on April, 2010 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7700341	April 20, 2010
‌ US Patent 7414108 Composition and method for producing an immune response against tumor-related antigens	Patent 7414108 was granted and assigned to Dendreon on August, 2008 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7414108	August 19, 2008
‌ US Patent 7413869 Method for determining potency of antigenic presenting cell based vaccines	Patent 7413869 was granted and assigned to Dendreon on August, 2008 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7413869	August 19, 2008
‌ US Patent 7560104 Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation	Patent 7560104 was granted and assigned to Dendreon on July, 2009 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7560104	July 14, 2009
‌ US Patent 7148324 Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation	Patent 7148324 was granted and assigned to Dendreon on December, 2006 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7148324	December 12, 2006
‌ US Patent 8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression	Patent 8389730 was granted and assigned to Dendreon on March, 2013 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	8389730	March 5, 2013
‌ US Patent 7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon	Patent 7888092 was granted and assigned to Dendreon on February, 2011 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7888092	February 15, 2011
‌ US Patent 8354507 HLA-DR specific antibodies, compositions and methods	Patent 8354507 was granted and assigned to Dendreon on January, 2013 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	8354507	January 15, 2013
‌ US Patent 7741355 Small-molecule modulators of TRP-p8 activity	Patent 7741355 was granted and assigned to Dendreon on June, 2010 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7741355	June 22, 2010
‌ US Patent 10261091 Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with improved clinical outcome	Patent 10261091 was granted and assigned to Dendreon on April, 2019 by the United States Patent and Trademark Office.	Dendreon	Dendreon	United States Patent and Trademark Office	10261091	April 16, 2019
‌ US Patent 7772266 Small-molecule modulators of TRP-P8 activity	Patent 7772266 was granted and assigned to Dendreon on August, 2010 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7772266	August 10, 2010
‌ US Patent 8658177 Promiscuous HER-2/Neu CD4 T cell epitopes	Patent 8658177 was granted and assigned to Dendreon on February, 2014 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	8658177	February 25, 2014
‌ US Patent 8647865 Promiscuous PAP CD4 T cell epitopes	Patent 8647865 was granted and assigned to Dendreon on February, 2014 by the United States Patent and Trademark Office.	Dendreon	Dendreon	United States Patent and Trademark Office	8647865	February 11, 2014
‌ US Patent 8361479 Promiscuous PAP CD4 T cell epitopes	Patent 8361479 was granted and assigned to Dendreon on January, 2013 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	8361479	January 29, 2013
‌ US Patent 8153120 Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity	Patent 8153120 was granted and assigned to Dendreon on April, 2012 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	8153120	April 10, 2012
‌ US Patent 7132398 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor	Patent 7132398 was granted and assigned to Dendreon on November, 2006 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7132398	November 7, 2006
‌ US Patent 9051385 Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease	Patent 9051385 was granted and assigned to Dendreon on June, 2015 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	9051385	June 9, 2015
‌ US Patent 7659117 Compositions and methods for dendritic cell-based immunotherapy	Patent 7659117 was granted and assigned to Dendreon on February, 2010 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7659117	February 9, 2010
‌ US Patent 8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression	Patent 8362264 was granted and assigned to Dendreon on January, 2013 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	8362264	January 29, 2013
‌ US Patent 7972602 Promiscuous HER-2/Neu CD4 T cell epitopes	Patent 7972602 was granted and assigned to Dendreon on July, 2011 by the United States Patent and Trademark Office.		Dendreon	United States Patent and Trademark Office	7972602	July 5, 2011

Results per page:

32 results

0 selected

32 results

0 selected